aluates Reports

$ 0.0

Automative

Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2026

Published Date: 2026-03-27

Report Code: QYRE-Auto-2U13185

Global mRNA Cancer Vaccines and Therapeutics Sales Market Report 2023

BUY CHAPTERS

Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2026

Code: QYRE-Auto-2U13185

Report

2026-03-27

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Moderna Therapeutics

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

Pfizer Inc

mRNA Cancer Vaccines and Therapeutics Market Size

The global mRNA Cancer Vaccines and Therapeutics market was valued at US$ 8232 million in 2025 and is anticipated to reach US$ 11530 million by 2032, at a CAGR of 5.0% from 2026 to 2032.

mRNA Cancer Vaccines and Therapeutics Market

mRNA cancer vaccines and therapeutics are a novel class of tumor immunotherapy products based on messenger RNA (mRNA) technology. This approach involves designing and delivering mRNA molecules encoding tumor-associated antigens, enabling the patient’s immune system to recognize and attack cancer cells, thereby achieving precise and effective anti-cancer responses. Compared to traditional cancer treatments, mRNA technology offers advantages such as shorter development cycles, flexible manufacturing, and strong potential for personalized customization, significantly enhancing treatment safety and efficacy. With rapid advances in biopharmaceuticals and gene editing technologies, mRNA cancer vaccines and therapeutics have emerged as a critical breakthrough in tumor immunotherapy, ushering cancer treatment into the era of precision immunotherapy.

The rising global cancer incidence and mortality rates drive urgent demand for innovative therapies to improve treatment outcomes and patient survival. Leading biopharmaceutical companies’ annual reports highlight sustained investments in mRNA technology platforms, accelerating R&D of cancer vaccines and therapeutics while ensuring safety and efficacy. Government support through policies and funding fosters faster clinical trials and market access. The flexibility and personalization capabilities of mRNA technology meet diverse needs across cancer types and patient populations, showing great potential especially in hard-to-treat and recurrent cancers. Global aging populations and the spread of precision medicine concepts further fuel rapid market growth.

Despite vast market potential, challenges remain. Complex and costly R&D processes with extended validation periods increase development risks. Regulatory environments are evolving, with divergent approval standards and pathways across countries complicating international commercialization. High R&D and manufacturing costs contribute to expensive therapies, limiting patient access in some regions. Intense competition and complex interplay between traditional and emerging immunotherapies require companies to continuously innovate to sustain competitive advantage.

Downstream demand for mRNA cancer vaccines and therapeutics is moving toward diversification and precision. Major comprehensive hospitals and oncology centers prioritize efficacy, safety, and personalized treatment regimens. Patient and market demand for innovative and effective therapies drives growth in personalized mRNA vaccine customization services, fostering a precision medicine ecosystem. Advances in companion diagnostics and data-driven decision-making enable more precise patient stratification and improved clinical outcomes. Accelerated integration of biotech and information technology will expand mRNA cancer therapies to broader cancer types and more complex treatment scenarios.

This report delivers a comprehensive overview of the global mRNA Cancer Vaccines and Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding mRNA Cancer Vaccines and Therapeutics. The mRNA Cancer Vaccines and Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global mRNA Cancer Vaccines and Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist mRNA Cancer Vaccines and Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of mRNA Cancer Vaccines and Therapeutics Market Report

Report Metric	Details
Report Name	mRNA Cancer Vaccines and Therapeutics Market
Accounted market size in 2025	US$ 8232 million
Forecasted market size in 2032	US$ 11530 million
CAGR	5.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Adeno Carcinomas Mucinous Carcinomas Adenosquamous Carcinomas
Segment by Application	Infectious Disease Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Moderna Therapeutics, Pfizer, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for mRNA Cancer Vaccines and Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is mRNA Cancer Vaccines and Therapeutics Market growing?

Ans: The mRNA Cancer Vaccines and Therapeutics Market witnessing a CAGR of 5.0% during the forecast period 2026-2032.

What is the mRNA Cancer Vaccines and Therapeutics Market size in 2032?

Ans: The mRNA Cancer Vaccines and Therapeutics Market size in 2032 will be US$ 11530 million.

Who are the main players in the mRNA Cancer Vaccines and Therapeutics Market report?

Ans: The main players in the mRNA Cancer Vaccines and Therapeutics Market are Moderna Therapeutics, Pfizer, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology

What are the Application segmentation covered in the mRNA Cancer Vaccines and Therapeutics Market report?

Ans: The Applications covered in the mRNA Cancer Vaccines and Therapeutics Market report are Infectious Disease, Cancer, Others

What are the Type segmentation covered in the mRNA Cancer Vaccines and Therapeutics Market report?

Ans: The Types covered in the mRNA Cancer Vaccines and Therapeutics Market report are Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Adeno Carcinomas

1.2.3 Mucinous Carcinomas

1.2.4 Adenosquamous Carcinomas

1.3 Market by Application

1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Infectious Disease

1.3.3 Cancer

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2021–2032)

2.2 Global mRNA Cancer Vaccines and Therapeutics Growth Trends by Region

2.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Size by Region (2021–2026)

2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2027–2032)

2.3 mRNA Cancer Vaccines and Therapeutics Market Dynamics

2.3.1 mRNA Cancer Vaccines and Therapeutics Industry Trends

2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers

2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges

2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue

3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2021–2026)

3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2021–2026)

3.2 Global Top mRNA Cancer Vaccines and Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by mRNA Cancer Vaccines and Therapeutics Revenue

3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio

3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2025

3.5 Global Key Players of mRNA Cancer Vaccines and Therapeutics Head Offices and Areas Served

3.6 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Products and Applications

3.7 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type

4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2021–2026)

4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2027–2032)

5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application

5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2021–2026)

5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2021–2032)

6.2 North America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2021–2026)

6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2021–2032)

7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2021–2026)

7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2021–2032)

8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2021–2026)

8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2021–2032)

9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2021–2026)

9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2021–2032)

10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2021–2026)

10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Moderna Therapeutics

11.1.1 Moderna Therapeutics Company Details

11.1.2 Moderna Therapeutics Business Overview

11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction

11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.1.5 Moderna Therapeutics Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer mRNA Cancer Vaccines and Therapeutics Introduction

11.2.4 Pfizer Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.2.5 Pfizer Recent Development

11.3 Translate Bio

11.3.1 Translate Bio Company Details

11.3.2 Translate Bio Business Overview

11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction

11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.3.5 Translate Bio Recent Development

11.4 BioNTech

11.4.1 BioNTech Company Details

11.4.2 BioNTech Business Overview

11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction

11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.4.5 BioNTech Recent Development

11.5 Sangamo Therapeutics

11.5.1 Sangamo Therapeutics Company Details

11.5.2 Sangamo Therapeutics Business Overview

11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction

11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.5.5 Sangamo Therapeutics Recent Development

11.6 Argos Therapeutics

11.6.1 Argos Therapeutics Company Details

11.6.2 Argos Therapeutics Business Overview

11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction

11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.6.5 Argos Therapeutics Recent Development

11.7 In-Cell-Art

11.7.1 In-Cell-Art Company Details

11.7.2 In-Cell-Art Business Overview

11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction

11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.7.5 In-Cell-Art Recent Development

11.8 eTheRNA

11.8.1 eTheRNA Company Details

11.8.2 eTheRNA Business Overview

11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction

11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.8.5 eTheRNA Recent Development

11.9 Ethris

11.9.1 Ethris Company Details

11.9.2 Ethris Business Overview

11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction

11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.9.5 Ethris Recent Development

11.10 Tiba Biotechnology

11.10.1 Tiba Biotechnology Company Details

11.10.2 Tiba Biotechnology Business Overview

11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction

11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

11.10.5 Tiba Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Moderna Therapeutics

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

Pfizer Inc

List of Tables

Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Adeno Carcinomas

Table 3. Key Players of Mucinous Carcinomas

Table 4. Key Players of Adenosquamous Carcinomas

Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million), 2021–2026

Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2021–2026)

Table 9. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2027–2032)

Table 11. mRNA Cancer Vaccines and Therapeutics Market Trends

Table 12. mRNA Cancer Vaccines and Therapeutics Market Drivers

Table 13. mRNA Cancer Vaccines and Therapeutics Market Challenges

Table 14. mRNA Cancer Vaccines and Therapeutics Market Restraints

Table 15. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (US$ Million), 2021–2026

Table 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2021–2026)

Table 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on mRNA Cancer Vaccines and Therapeutics Revenue, 2025

Table 18. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Products and Applications

Table 22. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (US$ Million), 2021–2026

Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2021–2026)

Table 26. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2027–2032)

Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (US$ Million), 2021–2026

Table 29. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2021–2026)

Table 30. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2027–2032)

Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 47. Moderna Therapeutics Company Details

Table 48. Moderna Therapeutics Business Overview

Table 49. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product

Table 50. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 51. Moderna Therapeutics Recent Development

Table 52. Pfizer Company Details

Table 53. Pfizer Business Overview

Table 54. Pfizer mRNA Cancer Vaccines and Therapeutics Product

Table 55. Pfizer Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 56. Pfizer Recent Development

Table 57. Translate Bio Company Details

Table 58. Translate Bio Business Overview

Table 59. Translate Bio mRNA Cancer Vaccines and Therapeutics Product

Table 60. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 61. Translate Bio Recent Development

Table 62. BioNTech Company Details

Table 63. BioNTech Business Overview

Table 64. BioNTech mRNA Cancer Vaccines and Therapeutics Product

Table 65. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 66. BioNTech Recent Development

Table 67. Sangamo Therapeutics Company Details

Table 68. Sangamo Therapeutics Business Overview

Table 69. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product

Table 70. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 71. Sangamo Therapeutics Recent Development

Table 72. Argos Therapeutics Company Details

Table 73. Argos Therapeutics Business Overview

Table 74. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product

Table 75. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 76. Argos Therapeutics Recent Development

Table 77. In-Cell-Art Company Details

Table 78. In-Cell-Art Business Overview

Table 79. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product

Table 80. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 81. In-Cell-Art Recent Development

Table 82. eTheRNA Company Details

Table 83. eTheRNA Business Overview

Table 84. eTheRNA mRNA Cancer Vaccines and Therapeutics Product

Table 85. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 86. eTheRNA Recent Development

Table 87. Ethris Company Details

Table 88. Ethris Business Overview

Table 89. Ethris mRNA Cancer Vaccines and Therapeutics Product

Table 90. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 91. Ethris Recent Development

Table 92. Tiba Biotechnology Company Details

Table 93. Tiba Biotechnology Business Overview

Table 94. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product

Table 95. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (US$ Million), 2021–2026

Table 96. Tiba Biotechnology Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. mRNA Cancer Vaccines and Therapeutics Picture

Figure 2. Global mRNA Cancer Vaccines and Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2025 vs 2032

Figure 4. Adeno Carcinomas Features

Figure 5. Mucinous Carcinomas Features

Figure 6. Adenosquamous Carcinomas Features

Figure 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (US$ Million), 2021–2032

Figure 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2025 vs 2032

Figure 9. Infectious Disease Case Studies

Figure 10. Cancer Case Studies

Figure 11. Others Case Studies

Figure 12. mRNA Cancer Vaccines and Therapeutics Report Years Considered

Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region: 2025 vs 2032

Figure 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2025

Figure 17. Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2025

Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2021–2032)

Figure 21. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2021–2032)

Figure 25. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Region (2021–2032)

Figure 33. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2021–2032)

Figure 41. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Country (2021–2032)

Figure 45. Israel mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 49. Pfizer Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 50. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 51. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 52. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 53. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 54. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 55. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 56. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 57. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2021–2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global RNA Vaccines Market Insights Forecast to 2030

Global mRNA Treatment Market Research Report 2024

Global mRNA Therapy Market Research Report 2024

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Vaccines and mRNA Drugs Market Research Report 2024

mRNA Sequencing

mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Development and Manufacturing Services Market Research Report 2025

Global Therapeutic Cancer Vaccines Market Research Report 2024

Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Synthesis Manufacturing Market Research Report 2024

Global mRNA Flu Vaccine Market Research Report 2024

Global mRNA Vaccine Raw Materials Market Research Report 2024

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global mRNA Vaccine Core Enzyme Market Research Report 2025

mRNA Vaccine and Therapeutics Raw Material Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Delivery System Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions